
Sunshine Biopharma Inc. warrant
SBFMW
SBFMW: Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).
moreShow SBFMW Financials
Recent trades of SBFMW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SBFMW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on SBFMW's company Twitter account
Number of mentions of SBFMW in WallStreetBets Daily Discussion
Recent insights relating to SBFMW
Recent picks made for SBFMW stock on CNBC
ETFs with the largest estimated holdings in SBFMW
Flights by private jets registered to SBFMW